ARMP

Conviction 27HealthcareScan · Thu, Jun 25, 2026

ARMP$6.60-10.20%

ResistanceSupportVol 14

Vol MA14 85.78K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Armata Pharmaceuticals, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.armatapharma.com ↗

Price6.60

Change-10.20%

Gap+2.38%

Rel volume0.75×

Avg volume81.03K

Avg $ vol602.06K

SMA 207.42

SMA 508.91

SMA 2007.30

Price vs 50-25.96%

Price vs 200-9.60%

MA stackmixed

50/200 cross—

Supertrenddown · 9.00

RSI (14)36

MACD hist0.03

MACD crossbull · 5d

Stoch %K / %D14 / 35

ADX (14)34

+DI / −DI8 / 21

RSI divergence—

MACD divergence—

ATR %+12.15%

ADR %9.19%

52w high14.80

52w low1.89

From 52w high-55.41%

Above 52w low+249.21%

New 52w highNo

SqueezeOn · 23d

Bollinger width23.51%

%B0.03

Donchian pos10.98%

Donchian high8.46

Donchian low6.37

AVWAP (52w high)8.38

vs AVWAP high-21.23%

AVWAP (52w low)8.16

vs AVWAP low-19.14%

OBV trendUp

Chaikin MF (20)0.16

Today vs 20d0.75×

Avg vol (14d)85.78K

Avg vol (20d)81.03K

Avg $ vol (20d)602.06K

Market cap242.29K

RS 3m (vs SPY)-22.73%

RS 6m (vs SPY)+11.58%

RS line new highNo

Trend template4/8

Technical rank28.2

1 week-6.52%

1 month-19.22%

3 months-23.34%

6 months+3.61%

1 year+251.06%

YTD+0.61%

P/E-0.00

P/B-0.00

P/S—

P/FCF-0.01

EPS-4.80

Div yield33.02%

ROE55.78%

ROA-249.00%

Debt/Eq—

Current0.64

EV/EBITDA0.13

Gross margin—

Net margin—

Rev growth—

EPS growth-818.79%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-4.51M

Revenue31K

Net income-115.35M

Gross profit—

Free cash flow-26.3M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out36.71M

Employees61

ListedFri, May 27, 1994

Free float20.26M

Float %55.2%

Short interest209.36K

Days to cover2.5d

Short volume63.0%

Squeeze score30 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank28.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance10.17

Support6.38

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARMP

All disclosures →

No recent disclosed trades by Congress in ARMP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARMP · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Gilmer Daniel B. Director · Stock Options (Right to Buy) · 2026-04-24	Grant	51.28K	$0	2026-04-24	2026-04-28

SEC filings

EDGAR filings in ARMP · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.